Note 21 - Share-based Compensation Expenses

3 Months Ended

Mar. 31, 2024

Notes to Financial Statements

Share-Based Payment Arrangement [Text Block]

21. Share-based compensation expenses

For the three months ended March 31, 2024, the Company did not record any share-based compensation expenses.

In June 2022, the Company granted and issued 0.08 million fully-vested and non-forfeitable shares of the Company restricted common stock to a management consulting and advisory service provider in exchange for its service for a 12-month period until May 2023. The Company valued these shares at US$1.75 per share, the closing bid price of the Company’s common stock on the grant date of these shares and recorded the related total cost of approximately US$0.14 million as a prepayment asset in prepayment and deposit to suppliers account upon the grant and issuance of these shares. Total compensation expenses amortized was approximately US$0.04 million for the three months ended March 31, 2023.

The table below summarized share-based compensation expenses recorded for the three months ended March 31, 2024 and 2023, respectively:

	Three Months Ended March 31,
	2024		2023
	US$(’000)		US$(’000)
	(Unaudited)		(Unaudited)
Sales and marketing expenses		-		-
General and administrative expenses		-		35
Research and development expenses		-		-
Total		-		35